Indomethacin sodium hydrate - CAS# 74252-25-8 Catalog No.:M16485-C 30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8

30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8

Palomid 529 (P529) inhibits the TORC1 and TORC2 complexes and shows both inhibition of Akt signaling and mTOR signaling similarly in tumor and vasculature

Solubility: DMSO 48 mg/mL (199

is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities

Formula: C44H88NO8P

Indomethacin sodium hydrate - CAS# 74252-25-8 Catalog No.:M16485-C 30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8Indomethacin sodium hydrate (Indometacin sodium hydrate) is a potent, blood brain permeable and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for human COX 1 and COX 2, respectively, in CHO cells. Indomethacin sodium hydrate disrupts autophagic flux by disturbing the normal functioning of lysosomes. Product information CAS Number: 74252 25 8 Molecular Weight: 433. 82 Formula: C19H21ClNNaO7 Chemical Name: sodium 2 [1 (4